【4527】ロート製薬

目薬(一般用医薬品)

類似企業：

【業界1位】小野薬品工業

【売上同水準】参天製薬 ツムラ

東証プライム

医薬品医薬

＞

その他医療・医薬品医他

売上高

営業利益

経常利益

当期利益

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2025.03	2024/11/13	Q2予	320,000	→	0.0%	+6.7%	43,200	→	0.0%	+0.5%	44,200	→	0.0%	+0.5%	32,200	→	0.0%	+0.6%
2025.03	2024/08/07	Q1予	320,000	↑	+6.7%	+6.7%	43,200	↑	+0.5%	+0.5%	44,200	↑	+0.5%	+0.5%	32,200	↑	+0.6%	+0.6%
2025.03	2024/05/13	当初予	300,000	-	-	-	43,000	-	-	-	44,000	-	-	-	32,000	-	-	-
2024.03	2024/05/13	実	270,840	↓	-0.4%	+4.6%	40,048	↑	+0.1%	+14.4%	42,434	↑	+2.3%	+17.9%	30,936	↑	+3.1%	+16.7%
2024.03	2024/02/09	Q3予	272,000	↑	+0.7%	+5.0%	40,000	↑	+3.9%	+14.3%	41,500	↑	+3.8%	+15.3%	30,000	↑	+3.4%	+13.2%
2024.03	2023/11/10	Q2予	270,000	↑	+2.7%	+4.2%	38,500	↑	+4.1%	+10.0%	40,000	↑	+5.3%	+11.1%	29,000	↑	+5.5%	+9.4%
2024.03	2023/08/09	Q1予	263,000	↑	+1.5%	+1.5%	37,000	↑	+5.7%	+5.7%	38,000	↑	+5.6%	+5.6%	27,500	↑	+3.8%	+3.8%
2024.03	2023/05/12	当初予	259,000	-	-	-	35,000	-	-	-	36,000	-	-	-	26,500	-	-	-
2023.03	2023/05/12	実	238,664	↑	+1.1%	+9.5%	33,959	↑	+2.9%	+21.3%	35,568	↑	+7.8%	+27.0%	26,377	↑	+9.9%	+35.3%
2023.03	2023/02/13	Q3予	236,000	↑	+2.6%	+8.3%	33,000	↑	+6.5%	+17.9%	33,000	↑	+3.1%	+17.9%	24,000	↑	+9.1%	+23.1%
2023.03	2022/11/10	Q2予	230,000	↑	+2.2%	+5.5%	31,000	↑	+3.3%	+10.7%	32,000	↑	+3.2%	+14.3%	22,000	↑	+2.3%	+12.8%
2023.03	2022/08/09	Q1予	225,000	↑	+3.2%	+3.2%	30,000	↑	+7.1%	+7.1%	31,000	↑	+10.7%	+10.7%	21,500	↑	+10.3%	+10.3%
2023.03	2022/05/12	当初予	218,000	-	-	-	28,000	-	-	-	28,000	-	-	-	19,500	-	-	-
2022.03	2022/05/12	実	199,646	↑	+2.4%	+9.7%	29,349	↑	+4.8%	+27.1%	29,084	↑	+3.9%	+21.7%	21,018	↑	+7.8%	+22.9%
2022.03	2022/02/10	Q3予	195,000	↑	+2.6%	+7.1%	28,000	↑	+12.0%	+21.2%	28,000	↑	+12.0%	+17.2%	19,500	↑	+8.3%	+14.0%
2022.03	2021/11/11	Q2予	190,000	↑	+4.4%	+4.4%	25,000	↑	+8.2%	+8.2%	25,000	↑	+4.6%	+4.6%	18,000	↑	+5.3%	+5.3%
2022.03	2021/08/10	Q1予	182,000	→	0.0%	0.0%	23,100	→	0.0%	0.0%	23,900	→	0.0%	0.0%	17,100	→	0.0%	0.0%
2022.03	2021/05/12	当初予	182,000	-	-	-	23,100	-	-	-	23,900	-	-	-	17,100	-	-	-
2021.03	2021/05/12	実	181,287	↓	-0.9%	-0.9%	22,990	↑	+5.5%	+5.5%	23,910	↑	+8.2%	+8.2%	16,743	↑	+19.6%	+19.6%
2021.03	2021/02/10	Q3予	183,000	→	0.0%	0.0%	21,800	→	0.0%	0.0%	22,100	→	0.0%	0.0%	14,000	→	0.0%	0.0%
2021.03	2020/11/12	Q2予	183,000	→	0.0%	0.0%	21,800	→	0.0%	0.0%	22,100	→	0.0%	0.0%	14,000	→	0.0%	0.0%
2021.03	2020/08/11	Q1予	183,000	→	0.0%	0.0%	21,800	→	0.0%	0.0%	22,100	→	0.0%	0.0%	14,000	→	0.0%	0.0%
2021.03	2020/05/12	当初予	183,000	-	-	-	21,800	-	-	-	22,100	-	-	-	14,000	-	-	-
2020.03	2020/05/12	実	188,327	↑	+2.4%	+2.4%	23,085	↑	+7.4%	+7.4%	22,735	↑	+6.7%	+6.7%	15,410	↑	+14.1%	+14.1%
2020.03	2020/02/12	Q3予	184,000	→	0.0%	0.0%	21,500	→	0.0%	0.0%	21,300	→	0.0%	0.0%	13,500	→	0.0%	0.0%
2020.03	2019/11/13	Q2予	184,000	→	0.0%	0.0%	21,500	→	0.0%	0.0%	21,300	→	0.0%	0.0%	13,500	→	0.0%	0.0%
2020.03	2019/08/08	Q1予	184,000	→	0.0%	0.0%	21,500	→	0.0%	0.0%	21,300	→	0.0%	0.0%	13,500	→	0.0%	0.0%
2020.03	2019/05/10	当初予	184,000	-	-	-	21,500	-	-	-	21,300	-	-	-	13,500	-	-	-
2019.03	2019/05/10	実	183,582	↑	+0.2%	+4.3%	20,812	↓	-2.7%	+6.7%	18,970	↓	-13.0%	-3.2%	9,799	↓	-26.3%	-17.7%
2019.03	2019/02/13	Q3予	183,300	→	0.0%	+4.1%	21,400	→	0.0%	+9.7%	21,800	→	0.0%	+11.2%	13,300	→	0.0%	+11.8%
2019.03	2018/11/13	Q2予	183,300	↑	+4.1%	+4.1%	21,400	↑	+9.7%	+9.7%	21,800	↑	+11.2%	+11.2%	13,300	↑	+11.8%	+11.8%
2019.03	2018/08/09	Q1予	176,000	→	0.0%	0.0%	19,500	→	0.0%	0.0%	19,600	→	0.0%	0.0%	11,900	→	0.0%	0.0%
2019.03	2018/05/11	当初予	176,000	-	-	-	19,500	-	-	-	19,600	-	-	-	11,900	-	-	-
2018.03	2018/05/11	実	171,742	↑	+4.1%	+8.4%	19,087	↑	+13.6%	+22.4%	18,849	↑	+11.5%	+17.8%	9,289	↓	-11.5%	-8.9%
2018.03	2018/02/09	Q3予	165,000	→	0.0%	+4.1%	16,800	→	0.0%	+7.7%	16,900	→	0.0%	+5.6%	10,500	→	0.0%	+2.9%
2018.03	2017/11/10	Q2予	165,000	→	0.0%	+4.1%	16,800	↑	+7.7%	+7.7%	16,900	→	0.0%	+5.6%	10,500	→	0.0%	+2.9%
2018.03	2017/11/02	修正予	165,000	↑	+4.1%	+4.1%	-	-	-	-	16,900	↑	+5.6%	+5.6%	10,500	↑	+2.9%	+2.9%
2018.03	2017/08/08	Q1予	158,500	→	0.0%	0.0%	15,600	→	0.0%	0.0%	16,000	→	0.0%	0.0%	10,200	→	0.0%	0.0%
2018.03	2017/05/11	当初予	158,500	-	-	-	15,600	-	-	-	16,000	-	-	-	10,200	-	-	-
2017.03	2017/05/11	実	154,599	↓	0.0%	-5.2%	15,451	↓	-0.3%	-0.3%	15,964	↑	+3.0%	+5.0%	10,011	↑	+0.1%	+5.4%
2017.03	2017/04/28	修正予	154,600	↑	+2.7%	-5.2%	15,500	↑	+18.3%	0.0%	15,500	↑	+15.7%	+2.0%	10,000	↑	+33.3%	+5.3%
2017.03	2017/02/08	Q3予	150,500	→	0.0%	-7.7%	13,100	→	0.0%	-15.5%	13,400	→	0.0%	-11.8%	7,500	→	0.0%	-21.1%
2017.03	2016/11/11	Q2予	150,500	↓	-7.7%	-7.7%	13,100	↓	-15.5%	-15.5%	13,400	↓	-11.8%	-11.8%	7,500	↓	-21.1%	-21.1%
2017.03	2016/05/13	当初予	163,000	-	-	-	15,500	-	-	-	15,200	-	-	-	9,500	-	-	-
2016.03	2016/05/13	実	167,016	↓	-0.3%	+1.8%	15,683	↑	+3.9%	+14.5%	15,339	↑	+1.6%	+8.8%	9,098	↓	-4.2%	+3.4%
2016.03	2016/02/09	Q3予	167,500	→	0.0%	+2.1%	15,100	→	0.0%	+10.2%	15,100	→	0.0%	+7.1%	9,500	→	0.0%	+8.0%
2016.03	2015/11/11	Q2予	167,500	→	0.0%	+2.1%	15,100	→	0.0%	+10.2%	15,100	→	0.0%	+7.1%	9,500	→	0.0%	+8.0%
2016.03	2015/11/04	修正予	167,500	↑	+2.1%	+2.1%	15,100	↑	+10.2%	+10.2%	15,100	↑	+7.1%	+7.1%	9,500	↑	+8.0%	+8.0%
2016.03	2015/08/06	Q1予	164,000	→	0.0%	0.0%	13,700	→	0.0%	0.0%	14,100	→	0.0%	0.0%	8,800	→	0.0%	0.0%
2016.03	2015/05/14	当初予	164,000	-	-	-	13,700	-	-	-	14,100	-	-	-	8,800	-	-	-
2015.03	2015/05/14	実	151,774	↓	-0.1%	-0.1%	13,159	↓	-6.0%	-22.6%	14,098	↓	-2.8%	-18.0%	8,631	↓	-4.1%	-18.6%
2015.03	2015/02/06	Q3予	152,000	→	0.0%	0.0%	14,000	↓	-9.7%	-17.6%	14,500	↓	-9.4%	-15.7%	9,000	↓	-10.0%	-15.1%
2015.03	2014/11/11	Q2予	152,000	→	0.0%	0.0%	15,500	↓	-8.8%	-8.8%	16,000	↓	-3.0%	-7.0%	10,000	↓	-1.0%	-5.7%
2015.03	2014/08/07	Q1予	152,000	→	0.0%	0.0%	-	-	-	-	16,500	↓	-4.1%	-4.1%	10,100	↓	-4.7%	-4.7%
2015.03	2014/05/14	当初予	152,000	-	-	-	17,000	-	-	-	17,200	-	-	-	10,600	-	-	-
2014.03	2014/05/14	実	143,822	↑	+0.0%	+0.0%	16,821	↑	+0.1%	+0.1%	17,100	→	0.0%	0.0%	8,947	↓	-0.6%	-0.6%
2014.03	2014/05/12	当初予	143,800	-	-	-	16,800	-	-	-	17,100	-	-	-	9,000	-	-	-

【4527】ロート製薬 目薬(一般用医薬品) 類似企業： 【業界1位】 小野薬品工業 【売上同水準】 参天製薬 ツムラ

【4527】ロート製薬

目薬(一般用医薬品)

類似企業：

【業界1位】小野薬品工業

【売上同水準】参天製薬ツムラ